Nicholas Company’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Nicholas Company’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-409,440	Closed	-$7.64M	–	239
2022 Q1	$7.64M	Buy	409,440 +535	+0.1%	+$9.63K	0.14%	168
2021 Q4	$8.75M	Buy	408,905 +123,745	+43%	+$2.44M	0.14%	162
2021 Q3	$5.27M	Buy	+285,160	New	+$5.74M	0.09%	212

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nicholas Company's OCDX Position: Q2 2022 in Review

Nicholas Company sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 409,440 shares — an estimated $7.64M sold.

Nicholas Company first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $8.75M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Nicholas Company reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Nicholas Company sold 409,440 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $7.64M.
Nicholas Company first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Nicholas Company's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $8.75M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Nicholas Company's 13F filing for Q2 2022, filed 26 Jul 2022.